These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6159910)

  • 1. Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.
    Norfolk D; Child JA; Cooper EH; Kerruish S; Ward AM
    Br J Cancer; 1980 Oct; 42(4):510-5. PubMed ID: 6159910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosis.
    Child JA; Crawford SM; Norfolk DR; O'Quigley J; Scarffe JH; Struthers LP
    Br J Cancer; 1983 Jan; 47(1):111-4. PubMed ID: 6185132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of the determination of beta-2-microglobulin in the monitoring of myeloma. Apropos of 290 determinations].
    Kaltwasser P; Sauger F; Le Loet X; Pasquis P; Monconduit M; Deshayes P
    Rev Rhum Mal Osteoartic; 1982 Apr; 49(5):359-63. PubMed ID: 6179150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum ferritin and beta-2-microglobulin in multiple myeloma].
    Linkesch W; Ludwig H
    Acta Med Austriaca; 1982; 9(5-6):227-31. PubMed ID: 6187172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognostic value of serum beta 2 microglobulin in myelomatosis.
    Cuzick J; De Stavola BL; Cooper EH; Chapman C; MacLennan IC
    Br J Haematol; 1990 Aug; 75(4):506-10. PubMed ID: 2119793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis.
    Cuzick J; Cooper EH; MacLennan IC
    Br J Cancer; 1985 Jul; 52(1):1-6. PubMed ID: 3893505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum ferritin and beta 2-microglobulin in patients with multiple myeloma.
    Linkesch W; Ludwig H
    Cancer Detect Prev; 1983; 6(1-2):297-301. PubMed ID: 6192921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary excretion of beta 2-microglobulin in myeloma patients.
    Engström W; Hyldahl L; Wahrgren P
    Clin Chim Acta; 1980 Dec; 108(3):369-74. PubMed ID: 6162592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of pretreatment serum beta 2-microglobulin levels in multiple myeloma.
    Scarffe JH; Anderson H; Palmer MK; Crowther D
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1361-4. PubMed ID: 6357802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serum beta-2-microglobulin in multiple myeloma. Practical value].
    Bataille R; Magub M; Sany J; Donadio D; Izarn P; Grenier J; Suquet P
    Rev Rhum Mal Osteoartic; 1981 Mar; 48(3):235-40. PubMed ID: 6164091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum beta-2-microglobulin estimation as an indicator of the glomerular filtration rate.
    Jialal I; Nathoo BC; Bejai S; Joubert SM
    S Afr Med J; 1982 Jun; 61(25):953-4. PubMed ID: 6178173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
    Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
    Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
    [No Abstract]   [Full Text] [Related]  

  • 13. Serum beta 2-microglobulin at remission and relapse in patients with multiple myeloma.
    Brenning G; Wibell L; Bergström R
    Eur J Clin Invest; 1985 Oct; 15(5):242-7. PubMed ID: 3935453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment serum beta 2-microglobulin in multiple myeloma.
    Brenning G; Simonsson B; Källander C; Ahre A
    Br J Haematol; 1986 Jan; 62(1):85-93. PubMed ID: 3510657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical studies on serum beta2-microglobulin in multiple myeloma and other related diseases (author's transl)].
    Nishioka F; Yachi A; Wada T
    Rinsho Ketsueki; 1978 Feb; 19(2):100-6. PubMed ID: 77342
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic and clinical studies of serum beta 2-microglobulin levels in haematological malignancies.
    Nakao Y; Matsumoto H; Miyazaki T; Watanabe S; Masaoka T; Takatsuki K; Kishihara M; Kobayashi N; Hattori M; Fujita T
    Clin Exp Immunol; 1981 Oct; 46(1):134-41. PubMed ID: 6175458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
    van Dobbenburgh OA; Rodenhuis S; Ockhuizen T; Weltevreden E; Houwen B; Fidler V; Meijer S; Marrink J
    Br J Haematol; 1985 Dec; 61(4):611-20. PubMed ID: 3910076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myeloma.
    Scudla V; Vavrdová V; Budíková M; Indrák K
    Acta Univ Palacki Olomuc Fac Med; 1991; 131():257-64. PubMed ID: 1840347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum beta-2-microglobulin levels in urological cancer.
    Bunning RA; Haworth SL; Cooper EH
    J Urol; 1979 May; 121(5):624-5. PubMed ID: 86616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [beta2-Microglobulin and monoclonal gammapathies (author's transl)].
    Belleville F; Bertrand F; Nabet P
    Pathol Biol (Paris); 1978 Sep; 26(6):348-50. PubMed ID: 83581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.